$ROL

ROLLINS INC

1
0
10

No SEC Form 4 filings for $ROL in the last 30 days.

See all $ROL insider activity →

Goldman Sachs Adjusts Rollins Price Target to $42 From $49

Goldman Sachs lowered its price target for Rollins, Inc. from $49 to $42. The company's stock is currently trading at $34.84, up 4.16% on the day and down 41.92% year-to-date. Rollins also held its Q3 2026 earnings call on October 22, 2026.

UBS maintains Rollins stock rating at Neutral on growth concerns

UBS kept Rollins (ROL) at Neutral with a $36.00 target after Q3 results. Organic growth was 4.4%, missing estimates. Shares fell 39% in six months. Q3 revenue was $1.09B, EPS $0.34, both below expectations. Rollins cut full-year organic growth outlook to 4-6%.

ROL sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 11 news stories mentioning ROL (ROLLINS INC). Coverage has skewed bearish: 1 bullish, 0 neutral, and 10 bearish.

Recent ROL coverage spans financial news, earnings and corporate actions.

What's driving ROL

  • Analyst upgrade with a higher target may boost the stock.

    theglobeandmail.com · Oct 24, 2026

  • Goldman Sachs lowered its price target for Rollins, Inc. from $49 to $42. The company's stock is currently trading at $34.84, up 4.16% on the day and down 41.92% year-to-date. Rollins also held its Q3 2026 earnings call on October 22, 2026.

    marketscreener.com · Oct 22, 2026

  • Rollins faces near‑term downside pressure as organic growth fell short of expectations.

    investing.com · Oct 22, 2026

  • Earnings miss.

    cnbc.com · Oct 22, 2026

  • Rollins, parent of Orkin, reported 100 straight quarters of revenue growth. Q3 2026 revenue rose 6.2% YoY to $1.1B, but net income fell 3.4% to $157.9M. Operating income declined 1.0% to $222.9M. Management cited customer acquisition challenges but remains confident in long-term growth. Operating cash flow increased 26.4% to $241.9M.

    stocktitan.net · Oct 21, 2026

AlphAI scores every news story that mentions ROL with an AI model for sentiment and relevance, and aggregates insider trades from ROLLINS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ROL

Score
$LMTLow

Stocks making the biggest moves premarket: Tesla, Meta, Aevex, Spotify & more

Aevex rose 11% disputing a report on halted Navy orders. Lockheed Martin gained 3% on strong Q3 results and raised guidance. Spotify climbed 5% with better-than-expected Q4 guidance. Tesla fell 3% despite earnings beat. IBM slipped 5% despite beating estimates. Meta dropped 2% despite revenue beat. CSX gained 2% on earnings beat. Las Vegas Sands fell 2% on disappointing results. Lam Research dropped 7% on Q2 guidance. QuantumScape surged 7% on AI data center battery plans.

$ROLMed

Bernstein cuts Rollins stock price target on margin concerns

Bernstein reduced its price target for Rollins (NYSE: ROL) to $35 from $42, citing margin concerns. The stock is down 39% over the past year. Analysts expect Q3 2026 earnings to miss estimates, with organic growth potentially below 5.7%. Multiple analysts have downgraded ROL, citing AI search impacts and increased competition.

$ROLMed

UBS cuts Rollins stock price target on choppy growth outlook

UBS reduced its price target for Rollins Inc. (ROL) to $36 from $43, citing choppy growth outlook. The stock has fallen over 40% in six months. InvestingPro values ROL at $37.83. UBS expects Q3 organic growth of 5.8%, in line with estimates. Multiple analysts have downgraded ROL due to market challenges and growth concerns. Earnings are due in seven days.

Related tickers